Divya Srikumaran

Divya Srikumaran

Auto-generated profile, based on publicly available information

Divya Srikumaran

Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
KWKendrick M. Wang
Kendrick M. Wang
AJAlbert S. Jun
Albert S. Jun
JLJohn G. Ladas
John G. Ladas
ASAazim A. Siddiqui
Aazim A. Siddiqui
FWFasika Woreta
Fasika Woreta
DSDivya Srikumaran
Divya Srikumaran

1 March 2022 in Ophthalmology
Verified
Journal Article
Closed access
SZSidra Zafar
Sidra Zafar
CDChen Dun
Chen Dun
DSDivya Srikumaran
Divya Srikumaran
PWPeiqi Wang
Peiqi Wang
OSOliver D. Schein
Oliver D. Schein
FWFasika Woreta
Fasika Woreta

13 January 2023 in Ophthalmology and Therapy
Verified
Journal Article
Open access
PDF file
MAMuhammad Ali
Muhammad Ali
KCKyongjin Cho
Kyongjin Cho
DSDivya Srikumaran
Divya Srikumaran
Corneal endothelium plays an important role in maintaining hydration homeostasis and clarity of the cornea. Fuchs endothelial corneal dystrophy (FECD) affects the corneal endothelium resulting in edema and characteristic excrescences on the Descemet’s membrane known as corneal guttae. Descemet membrane endothelial keratoplasty (DMEK) has evolved to become the standard of care for patients with FECD with excellent visual acuity outcomes. Patients with FECD may have coexisting cataracts and therefore may require a cataract surgery, which increases the risk of corneal decompensation. The presence of FECD may not only influence the choice of intraocular lens but vision outcomes can also be affected by the corneal condition. The ability to combine the surgeries further raises important considerations regarding the timing and sequence of DMEK and cataract extraction for patients with FECD. This review provides a guide for corneal surgeons in choosing between endothelial keratoplasty and cataract surgery—alone, in combination or sequential—in their management of patients with FECD.

1 May 2022 in Ophthalmology
Verified
Journal Article
Closed access
JMJui Malwankar
Jui Malwankar
HSHyeck-Soo Son
Hyeck-Soo Son
DCDavid F. Chang
David F. Chang
CDChen Dun
Chen Dun
FWFasika Woreta
Fasika Woreta
DSDivya Srikumaran
Divya Srikumaran

1 January 2021 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
SZSidra Zafar
Sidra Zafar
PWPeiqi Wang
Peiqi Wang
FWFacia A. Woreta
Facia A. Woreta
KAKanza Aziz
Kanza Aziz
MMMartin Makary
Martin Makary
DSDivya Srikumaran
Divya Srikumaran

21 September 2023 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
ACAriel Chen
Ariel Chen
CDChen Dun
Chen Dun
OSOliver D Schein
Oliver D Schein
DSDivya Srikumaran
Divya Srikumaran
SZSidra Zafar
Sidra Zafar
FWFasika Woreta
Fasika Woreta
Aims To determine endophthalmitis rates and risk factors following intraocular surgeries in the Medicare population. Methods Retrospective, cross-sectional study from 2016 to 2019 in Medicare fee-for-service and Medicare Advantage beneficiaries. 100% Medicare claims were used to identify eyes that underwent intraocular surgery. Exclusion criteria included eyes that had intraocular surgery 42 days before or after and eyes in patients with a history of endophthalmitis within 12 months. Results 9 744 400 intraocular surgeries were performed among Medicare beneficiaries from 2016 to 2019. A 42-day postoperative endophthalmitis rate was 0.09%. Endophthalmitis rate by surgery type was 0.43% for corneal transplant, 0.36% for secondary intraocular lens (IOL), 0.24% for retina, 0.16% for glaucoma, 0.11% for cataract combined with other procedures and 0.08% for cataract surgeries alone. On multivariable analysis, the risk of endophthalmitis was increased for all intraocular surgery types when compared with cataract surgeries; adjusted OR (aOR) 5.30 (p<0.01) for corneal transplant, aOR 4.50 (p<0.01) for secondary IOL, aOR 3.00 (p<0.01) for retina, aOR 1.93 (p<0.01) for glaucoma, aOR 1.45 (p<0.01) for combined cataract surgeries. Increased risk of developing endophthalmitis was associated with older age (≥85 vs 65–75 years: aOR 1.36; p<0.01), male sex (aOR 1.20; p<0.001) and greater Charlson Comorbidity Index (≥7 vs 0: aOR 1.79; p<0.01). Conclusions Postoperative endophthalmitis rate after intraocular surgeries was 0.09% between 2016 and 2019 for Medicare beneficiaries. Endophthalmitis rates were highest for corneal transplant surgeries followed by secondary IOL surgeries and lowest for cataract surgeries. Older age, male gender and higher comorbidity index were associated with risk of endophthalmitis.